Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $135

Benzinga · 2d ago
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $150 to $135.